About Laurus Bio
Laurus Bio is a Healthcare company based in Bengaluru (India) founded in 2005 by Rajesh Krishnamurthy, and was acquired by Laurus Labs in September 2023. Precision fermentation services for biopharma and food are provided. Laurus Bio has raised $18.89 million across 1 funding round from investors including Laurus Labs, Eight Roads Ventures and F-Prime Capital. The company has 548 employees. Its chief executive, as recorded, is Rajesh Krishnamurthy. Its Indian entity Laurus Bio Private Limited reported revenue of βΉ203 Cr. Laurus Bio offers products and services including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO. Its focus areas include Biopharma Outsourcing, CDMO and Biologics.
Company details
Laurus Bio was founded in 2005 in Bengaluru, India, as an integrated biomanufacturing organization. Precision fermentation is utilized to engineer microbes for producing animal-free proteins and growth factors. Services extend to the biopharma, food, and regenerative medicine sectors, including clone development, strain engineering, and large-scale manufacturing under cGMP standards. Operations support cultured meat, cell culture media, and vaccine production across various markets.
- Headquarters Bengaluru, India
- Employees 548
- Founders Rajesh Krishnamurthy
- Stage Acquired
- SectorsHealthcare
- Website laurus.bio
- Social LinkedIn
- Acquired by Laurus Labs (Sep 2023)
- Legal Name Laurus Bio Private Limited
- Date of Incorporation 14 Jul, 2005
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹203 Cr
FY 2026 · +18% YoY
- Net Profit₹6.72 Cr
FY 2026 · 3% margin
- EBITDA₹42.83 Cr
FY 2026 · 21% margin
- Total Equity Funding$18.89M (USD)
in 1 rounds
- Latest Funding Round$18.89M (USD), Series B
Dec 2024
- InvestorsLaurus Labs
& 2 more
- Employee Count548
- Acquired byLaurus Labs
(Sep 2023)
Associated legal entities of Laurus Bio
Laurus Bio is associated with 2 registered companies on The Company Check; the primary company is Laurus Bio Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Laurus Bio Private Limited CIN U02423KA2005PTC036770 | Active | 14 Jul 2005 | Bangalore, Karnataka | ₹203 Cr | 347 | 10 | View details |
| Laurus Labs Limited Listed CIN L24239AP2005PLC047518 | Active | 19 Sep 2005 | Anakapalle, Andhra Pradesh | ₹6,868 Cr | 5,881 | 13 | View details |
Products & Services of Laurus Bio
Laurus Bio offers a comprehensive portfolio of products and services, including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO.
Proteins and growth factors for safe medicines and sustainable food applications.
Services for strain engineering and fermentation scale-up in biopharma.
Funding Insights of Laurus Bio
Laurus Bio has successfully raised a total of $18.89M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.89 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.89M
- Total Rounds 1
- Last Round Series B β $18.89M
- First Round $18.89M
(Dec 2024)
- Investors Count 2
All 1 funding rounds of Laurus Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $18.89M | Series B | β | β |
3 investors in total: 3 institutional.
Investors in Laurus Bio
Laurus Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Laurus Labs, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com | |||
Pharmaceutical and biotechnology company | 2005 | lauruslabs.com | Hyderabad, India |
Investor details for Laurus Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Laurus Bio Private Limited (Laurus Bio)
Laurus Bio Private Limited is the primary company behind Laurus Bio. The boards of the 2 registered companies of Laurus Bio currently have 15 directors; the longest-serving is Satyanarayana Chava, appointed in 2006. 40 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satyanarayana Chava DIN 00211921 | Whole-time director | 21 Jan 2006 | 20 yrs 9 mo | Laurus Labs Limited, Laurus Bio Private Limited |
| Venkata Ravi Kumar Vantaram DIN 01424180 | Whole-time director | 30 Nov 2006 | 19 yrs 11 mo | Laurus Labs Limited, Laurus Bio Private Limited |
| Krishnakalyan Thiruvannamalai Dhandapani DIN 03102812 | Whole-time director | 23 May 2014 | 12 yrs 5 mo | Laurus Bio Private Limited |
| Rajesh Krishnamurthy DIN 03329827 | Whole-time director | 23 May 2014 | 12 yrs 5 mo | Laurus Bio Private Limited |
| Ravindranath Kancherla DIN 00117940 | Director | 18 May 2017 | 9 yrs 5 mo | Laurus Labs Limited |
| Venkata Lakshmana Rao Chunduru DIN 06885453 | Whole-time director | 08 Mar 2018 | 8 yrs 8 mo | Laurus Labs Limited |
| Uma Maheswar Rao Vasireddi DIN 03506390 | Director | 20 Jan 2021 | 5 yrs 9 mo | Laurus Bio Private Limited |
| Rajaram DIN 09047167 | Director | 30 Jan 2021 | 5 yrs 9 mo | Laurus Bio Private Limited |
| Sekar Karnam DIN 07400094 | Director | 25 Apr 2024 | 2 yrs 6 mo | Laurus Labs Limited, Laurus Bio Private Limited |
| Krishna Chaitanya Chava DIN 06831883 | Whole-time director | 25 Apr 2024 | 2 yrs 6 mo | Laurus Labs Limited |
| Soumya Chava DIN 06831892 | Whole-time director | 25 Apr 2024 | 2 yrs 6 mo | Laurus Labs Limited |
| Ramesh Subrahmanian DIN 02933019 | Director | 25 Jul 2024 | 2 yrs 3 mo | Laurus Labs Limited |
| Prem Pavoor DIN 05268309 | Director | 20 Dec 2024 | 1 yr 10 mo | Laurus Bio Private Limited |
| Sutapa Banerjee DIN 02844650 | Director | 02 Jul 2026 | 4 mo | Laurus Labs Limited |
| Shekhar Chintamani Mande DIN 10083454 | Director | 02 Jul 2026 | 4 mo | Laurus Labs Limited, Laurus Bio Private Limited |
People of Laurus Bio
9 people are tracked at Laurus Bio (2 in leadership, 7 in team); the tracked headcount is 548.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
Shashi Bala Prasad | Director (r&d) | Leadership |
Parthiban G | Senior Manager | Team |
Dr. Anup Sakekar | Scientist | Team |
Divya Mahesh | Senior Business Analyst | Team |
Tannavi Kiran | Scientist, R&d | Team |
Umashankara. K | Senior Electrical Executive | Team |
Naveen N | Scientist | Team |
Ashwin Bhat | Senior Manager | Team |
Complete people profiles for Laurus Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Laurus Bio
Figures of Laurus Bio Private Limited, the primary company behind Laurus Bio, for FY 2026. Revenue was ₹203 Cr (+18% year on year). Net profit was ₹6.72 Cr (3% margin). EBITDA was ₹42.83 Cr (21% margin). Revenue has grown at a compounded annual rate of +16% over three years and +31% over five years.
- ₹203 CrRevenue · FY 2026 · +18% YoY
- ₹6.72 CrNet profit · 3% margin
- ₹42.83 CrEBITDA · 21% margin
- ₹1.01 CrPaid-up capital
- 347Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +31%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Laurus Bio Private Limited are on its company page.
Detailed financial statements for Laurus Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Laurus Bio
3 dated milestones of Laurus Bio across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Laurus Bio is founded.
- Exit Acquired by Laurus Labs.
- Funding First funding round of $18.9M.
Web traffic of Laurus Bio
The website of Laurus Bio (laurus.bio) receives about 3.8K visits a month.
- Monthly visits3.8K
▼ 5.6% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Laurus Bio (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Laurus Bio
Complete news archive for Laurus Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laurus Bio
Laurus Bio was founded in 2005 and raised its 1st funding round 19 years after it was founded.
Laurus Bio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rajesh Krishnamurthy is the CEO of Laurus Bio, as recorded in our data. They have also founded this company.
Laurus Bio is a funded company, having raised a total of $18.89M across 1 funding round to date. The company's 1st funding round was a Series B of $18.89M, raised on Dec 2024.
Laurus Bio has 548 employees.
The primary company behind Laurus Bio, Laurus Bio Private Limited, reported revenue of βΉ203 Cr for FY 2026, up 18% year on year.
Laurus Bio was founded in 2005 in Bengaluru, India, as an integrated biomanufacturing organization. Precision fermentation is utilized to engineer microbes for producing animal-free proteins and growth factors. Services extend to the biopharma, food, and regenerative medicine sectors, including clone development, strain engineering, and large-scale manufacturing under cGMP standards. Operations support cultured meat, cell culture media, and vaccine production across various markets.
Laurus Bio offers Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO.
Laurus Bio has 3 investors. Key investors include Laurus Labs, Eight Roads Ventures, and F-Prime Capital.
Laurus Bio is associated with 2 legal entities: Laurus Bio Private Limited, Laurus Labs Limited.
Yes. Laurus Bio was acquired by Laurus Labs in September 2023.
The legal entities of Laurus Bio currently have 16 directors, including Venkateswar Reddy Gogireddy, Satyanarayana Chava, Venkata Ravi Kumar Vantaram and others.

